




版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
心臟病人非心臟手術(shù)術(shù)前評(píng)估與術(shù)中管理
江蘇省蘇北人民醫(yī)院麻醉科楊柳青
2009ESC/ESA指南ImpactFactor9.275Guidelinesandrecommendationsshouldhelpphysiciansandotherhealthcareproviderstomakedecisionsintheirdailypractice.However,thephysicianinchargeofhis/hercaremustmaketheultimatejudgementregardingthecareofanindividualpatientIntroductionThepresentguidelinesfocusonthecardiologicalmanagementofpatientsundergoingnon-cardiacsurgery,i.e.patientswhereheartdiseaseisapotentialsourceofcomplicationsduringsurgerymajornon-cardiacsurgeryisassociatedwithanincidenceofcardiacdeathofbetween0.5and1.5%,andofmajorcardiaccomplicationsofbetween2.0and3.5%ItisestimatedthatelderlypeoplerequiresurgeryfourtimesmoreoftenthantherestofthepopulationPre-operativeevaluationNo.3Surgicalriskforcardiacevents:theurgency,magnitude,type,anddurationoftheprocedure,aswellasthechangeinbodycoretemperature,bloodloss,andfluidshiftsNo.2No.1Functionalcapacity
Functionalcapacityismeasuredinmetabolicequivalents(METs)ExercisetestingprovidesanobjectiveassessmentoffunctionalcapacityWithouttesting,functionalcapacitycanbeestimatedbytheabilitytoperformtheactivitiesofdailyliving123<4METsindicatespoorfunctionalcapacityandisassociatedwithanincreasedincidenceofpost-operativecardiaceventsRiskindicesGoldman(1977),Detsky(1986),Lee(1999)TheLeeindex,tobethebestcurrentlyavailablecardiacriskpredictionindexinnon-cardiacsurgery12Sixindependentclinicaldeterminants(TheLeeindex)High-risktypeofsurgeryahistoryofIHDahistoryofcerebrovasculardiseaseheartfailureinsulin-dependentdiabetesmellitusimpairedrenalfunction030405060102TheLeeindexAllfactorscontributeequallytotheindex(with1pointeach)01theincidenceofmajorcardiaccomplicationsisestimatedat0.4,0.9,7,and11%inpatientswithanindexof0,1,2,and≥3points,respectively02BiomarkersCardiactroponinsTandI(cTnTandcTnI)arethepreferred1markersforthediagnosisofMIbecausetheydemonstratesensitivityandtissuespecificitysuperiortootheravailablebiomarkers2PlasmaBNPandNT-proBNPimportantprognosticindicatorsinpatientswithheartfailureadditionalprognosticvalueforlong-termmortalityandforcardiaceventsNon-invasivetesting01threecardiacriskmarkers:03myocardialischaemia02LVdysfunction04heartvalveabnormalitiesAmeta-analysisoftheavailabledatademonstratedthatanLVejectionfractionof<35%hadasensitivityof50%andaspecificityof91%forpredictionofperioperativenon-fatalMIorcardiacdeathawell-establishedinvasivediagnosticprocedure01rarelyindicatedtoassesstheriskofnoncardiacsurgery02AngiographyBesidesspecificriskreductionstrategiesadaptedtopatientcharacteristicsandthetypeofsurgery,preoperativeevaluationisanopportunitytocheckandoptimizethecontrolofallcardiovascularriskfactorsb-blockersThedoseofb-blockersshouldbetitrated,whichrequiresthattreatmentbeinitiatedoptimallybetween30daysandatleast1weekbeforesurgery.treatmentstartwithadailydoseof2.5mgofbisoprololor50mgofmetoprololsuccinatewhichshouldthenbeadjustedbeforesurgerytoachievearestingheartrateofbetween60and70bpmwithSBP>100mmHgSpecificdiseasesArterialhypertensionValvularheartdiseaseAorticstenosisMitralstenosisARandMRprostheticvalve(s)Arterialhypertension0102antihypertensivemedicationsshouldbecontinuedduringtheperioperativeperiod.Inpatientswithgrade3hypertension(systolicbloodpressure≧180mmHgand/ordiastolicbloodpressure≧110mmHg),thepotentialbenefitsofdelayingsurgerytooptimizethepharmacologicaltherapyshouldbeweighedagainsttheriskofdelayingthesurgicalprocedurehigherriskEchocardiographyshouldbeperformedAorticstenosisSevereAS:aorticvalvearea<1cm201<0.6cm2/m2bodysurfacearea)02Mitralstenosisrelativelylowrisk:non-significantmitralstenosis(MS)(valvearea>1.5cm2)andinasymptomaticpatientswithsignificantMS(valvearea<1.5cm2)andsystolicpulmonaryarterypressure<50mmHg1controlofheartrate2Strictcontroloffluidoverload3anticoagulation4AF5ARandMRNon-significantARandMR(lowrisk)asymptomaticpatientswithsevereARandMRandpreservedLVfunction(lowrisk)SymptomaticpatientsandLVEF<30%(Highrisk,onlyifnecessary,optimizationofpharmacologicaltherapy)prostheticvalve(s)noevidenceofvalveorventriculardysfunction(withoutadditionalrisk)endocarditisprophylaxisanticoagulationregimenmodification010302BradyarrhythmiasTemporarycardiacpacingisrarelyrequired,eveninthepresenceofpre-operativeasymptomaticbifascicularblockorCLBBBTheindicationsfortemporarypacemakersaregenerallythesameasthoseforpermanentpacemakersPacemaker/implantablecardioverterdefibrillatorunipolarelectrocauteryrepresentsasignificantriskbeavoidedbypositioningthegroundplateKeepingtheelectrocauterydeviceawayfromthepacemaker,givingonlybriefburstsandusingthelowestpossibleamplitudeTheimplantablecardioverterdefibrillatorshouldbeturnedoffduringsurgeryandswitchedonintherecoveryphasebeforedischargetothewardPerioperativemonitoring
V5(75%),V4(61%),V5+V4(90%),V5+V4+II(96%)ContinuousautomatedSTtrendingmonitors(sensitivityandspecificityof74and73%)ECGRightheartcatherizationbothalargeobservationalstudyandarandomizedmulticentreclinicaltrialdidnotshowabenefitassociatedwiththeuseofrightheartcatheterization01nodifferenceinmortalityandhospitalduration/ahigherincidenceofpulmonaryembolism02promotesatherosclerosis,endothelialdysfunction,andactivationofplateletsandproinflammatorycytokinesproper
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 農(nóng)業(yè)植保員職業(yè)考試真題試題及答案
- 游泳救生員應(yīng)急響應(yīng)流程試題及答案
- 2024農(nóng)業(yè)植保員前沿知識(shí)試題及答案
- 圍繞體育經(jīng)紀(jì)人的試題及答案深度分析
- 試題及答案解析模具設(shè)計(jì)的關(guān)鍵
- 聚焦農(nóng)作物種子市場(chǎng)的未來(lái)發(fā)展方向試題及答案
- 裁判員在裁判隊(duì)伍中的領(lǐng)導(dǎo)力試題及答案
- 2025年中國(guó)內(nèi)燃機(jī)零配件市場(chǎng)調(diào)查研究報(bào)告
- 2025年中國(guó)光磁記錄產(chǎn)品市場(chǎng)調(diào)查研究報(bào)告
- 2025年中國(guó)乳炎消油劑市場(chǎng)調(diào)查研究報(bào)告
- 《幼兒園課程圖景》閱讀分享
- 中海油考試試題及答案
- 女青春期教育
- 2025年第三屆天揚(yáng)杯建筑業(yè)財(cái)稅知識(shí)競(jìng)賽題庫(kù)附答案(101-200題)
- 2025年光伏逆變器市場(chǎng)前景分析
- 中國(guó)畫(huà)論知到課后答案智慧樹(shù)章節(jié)測(cè)試答案2025年春陜西師范大學(xué)
- 易制毒危險(xiǎn)化學(xué)品管理制度
- DB65T 8020-2024 房屋建筑與市政基礎(chǔ)設(shè)施工程施工現(xiàn)場(chǎng)從業(yè)人員配備標(biāo)準(zhǔn)
- GB/T 13511.2-2025配裝眼鏡第2部分:漸變焦定配眼鏡
- 酒店餐飲銷售培訓(xùn)
- 情報(bào)信息發(fā)布規(guī)范
評(píng)論
0/150
提交評(píng)論